Walling J M, Stratford I J, Adams G E
Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Jul;52(1):31-41. doi: 10.1080/09553008714551451.
CB 1954 (2,4-dinitro-5-aziridinyl benzamide) is a radiosensitizer which is up to 10 times more efficient in vitro than would be predicted on the basis of its electron affinity. In order to determine the contribution of the various functional groups comprising the molecule to overall sensitizing efficiency, nine structural analogues have been studied. The redox potential, E7(1), and sensitizing efficiency, C1.6, were obtained for each compound. The value of C1.6 depends on both redox potential and the magnitude of an additional component defined by C1.6/C1.6, where C1.6 is derived from a structure/activity relationship (Adams et al. 1979 b, Wardman 1982) described by the equation: log (C1.6/mol dm-3) = (6.96 +/- 0.22) + (9.54 +/- 0.56)E7(1)V. The magnitude of C1.6/C1.6 for CB 1954 and its analogues depends on alkyl substitution of the amide, the presence/absence and position of the nitro groups and is independent of the presence of the aziridine group. Holding cells in the presence of the drug post-irradiation marginally enhanced sensitization by CB 1954, CB 10-107 and by CB 10-092 but the largest effect was seen with the mononitro compound CB 7060 which also has a value of 26 for C1.6/C1.6. This compound was also interesting in that when combined with 2-phenyl-4(5)amino-5(4)-imidazole carboxamide (phenyl AIC) an enhancement of sensitization was obtained. In contrast, phenyl AIC protected against radiosensitization by CB 1954. Taken together, the data suggest that multiple mechanisms of radiosensitization may contribute to the abnormal radiosensitizing efficiency of CB 1954 and its analogues. This has implications for the further design and development of novel radiosensitizing drugs.
CB 1954(2,4-二硝基-5-氮丙啶基苯甲酰胺)是一种放射增敏剂,其在体外的效率比根据其电子亲和力预测的效率高10倍。为了确定构成该分子的各种官能团对整体增敏效率的贡献,已研究了九种结构类似物。获得了每种化合物的氧化还原电位E7(1)和增敏效率C1.6。C1.6的值取决于氧化还原电位以及由C1.6/C1.6定义的另一个组分的大小,其中C1.6源自结构/活性关系(亚当斯等人,1979年b;沃德曼,1982年),该关系由以下方程描述:log(C1.6/mol dm-3)=(6.96±0.22)+(9.54±0.56)E7(1)V。CB 1954及其类似物的C1.6/C1.6大小取决于酰胺的烷基取代、硝基的存在与否和位置,并且与氮丙啶基团的存在无关。在照射后将细胞置于药物存在下,CB 1954、CB 10 - 107和CB 10 - 092的增敏作用略有增强,但单硝基化合物CB 7060的效果最大,其C1.6/C1.6的值也为26。该化合物还有趣之处在于,当与2-苯基-4(5)氨基-5(4)-咪唑甲酰胺(苯基AIC)组合时,可获得增敏增强效果。相反,苯基AIC可防止CB 1954的放射增敏作用。综上所述,数据表明多种放射增敏机制可能导致CB 1954及其类似物异常的放射增敏效率。这对新型放射增敏药物的进一步设计和开发具有启示意义。